Literature DB >> 28139368

Noninvasive ventilation for acute exacerbations of asthma: A systematic review of the literature.

Elyce Green1, Paras Jain2, Maree Bernoth3.   

Abstract

BACKGROUND: Asthma is a chronic disease characterised by reversible airway obstruction caused by bronchospasm, mucous and oedema. People with asthma commonly experience acute exacerbations of their disease requiring hospitalisation and subsequent utilisation of economic and healthcare resources. Noninvasive ventilation has been suggested as a treatment for acute exacerbations of asthma due to its ability to provide airway stenting, optimal oxygen delivery and decreased work of breathing.
OBJECTIVES: This paper is a systematic review of the available published research focused on the use of noninvasive ventilation for the treatment of acute exacerbations of asthma to determine if this treatment provides better outcomes for patients compared to standard medical therapy.
METHOD: Database searches were conducted using EBSCOhost, MEDLINE and PubMed. Search terms used were combinations of 'noninvasive ventilation', 'BiPAP', 'CPAP', 'wheez*' and 'asthma'. Articles were included if they were research papers focused on adult patients with asthma and a treatment of noninvasive ventilation, and were published in full text in English. Included articles were reviewed using the National Health and Medical Research Council (Australia) evidence hierarchy and quality appraisal tools.
RESULTS: There were 492 articles identified from the database searches. After application of inclusion/exclusion criteria 13 articles were included in the systematic review. Studies varied significantly in design, endpoints and outcomes. There was a trend in better outcomes for patients with acute asthma who were treated with noninvasive ventilation compared to standard medical therapy, however, the variability of the studies meant that no conclusive recommendations could be made.
CONCLUSION: More research is required before noninvasive ventilation can be conclusively recommended for the treatment of acute exacerbations of asthma.
Copyright © 2017 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adults; Asthma; BiPAP; CPAP; Noninvasive ventilation; Systematic review

Mesh:

Year:  2017        PMID: 28139368     DOI: 10.1016/j.aucc.2017.01.003

Source DB:  PubMed          Journal:  Aust Crit Care        ISSN: 1036-7314            Impact factor:   2.737


  5 in total

1.  Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations.

Authors:  Meghan D Althoff; Fernando Holguin; Fan Yang; Gary K Grunwald; Marc Moss; R William Vandivier; P Michael Ho; Tyree H Kiser; Ellen L Burnham
Journal:  Am J Respir Crit Care Med       Date:  2020-12-01       Impact factor: 21.405

Review 2.  Chinese expert consensus-based guideline on assessment and management of asthma exacerbation.

Authors:  Jiangtao Lin; Bin Xing; Ping Chen; Mao Huang; Xin Zhou; Changgui Wu; Dong Yang; Kaisheng Yin; Shaoxi Cai; Xiaoming Cheng; Chuangli Hao; Changzheng Wang; Chuntao Liu
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

3.  Hospitalization and mortality for acute exacerbation of asthma: an Italian population-based study.

Authors:  Ombretta Para; Andrea Montagnani; Stefano Guidi; Lorenza Bertù; Dario Manfellotto; Mauro Campanini; Andrea Fontanella; Francesco Dentali
Journal:  Intern Emerg Med       Date:  2022-02-01       Impact factor: 5.472

4.  Adult Patients with Respiratory Distress: Current Evidence-based Recommendations for Prehospital Care.

Authors:  Sammy S Hodroge; Melody Glenn; Amelia Breyre; Bennett Lee; Nick R Aldridge; Karl A Sporer; Kristi L Koenig; Marianne Gausche-Hill; Angelo A Salvucci; Eric M Rudnick; John F Brown; Gregory H Gilbert
Journal:  West J Emerg Med       Date:  2020-06-25

Review 5.  Hypercapnia: An Aggravating Factor in Asthma.

Authors:  Masahiko Shigemura; Tetsuya Homma; Jacob I Sznajder
Journal:  J Clin Med       Date:  2020-10-05       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.